New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 18, 2014
08:50 EDTINSMInsmed breakthrough designation a 'game changer,' says Piper Jaffray
Piper Jaffray views the breakthrough designation for Arikayce for the treatment of nontuberculous mycobacterial as a "game changer" for Insmed. Piper expects shares to move sharply higher today and says the news brings the company "another important step closer toward approval." It reiterates an Overweight rating on Insmed with a $51 price target. The stock is up 27% in pre-open trading to $15.82.
News For INSM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 15, 2014
07:07 EDTINSMInsmed provides end of year regulatory and clinical update
Subscribe for More Information
December 11, 2014
09:17 EDTINSMInsmed management to meet with Leerink
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use